Jorge D. Brioni / Michael W. Decker (Hgg.)

Pharmacological Treatment of Alzheimer's Disease

Molecular and Neurobiological Foundations
Herausgegeben:Brioni, Jorge D.; Decker, Michael W.

• Gebundenes Buch

Produktbeschreibung

Geboten wird ein vollständiger, ausgewogener Überblick über die neuropharmakologischen Grundlagen von Therapeutika für die Alzheimer-Krankheit. Neueste Untersuchungen molekularer Strukturen und aktuelle klinische Daten werden mit der Verhaltens- und Erkenntnisforschung verknüpft und interpretiert.

Produktdetails

• Verlag: Wiley & Sons
• 1. Auflage
• Seitenzahl: 549
• Erscheinungstermin: 10. März 1997
• Englisch
• Abmessung: 240mm x 161mm x 35mm
• Gewicht: 992g
• ISBN-13: 9780471167587
• ISBN-10: 0471167584
• Artikelnr.: 13794611

Autorenporträt

Jorge D. Brioni and Michael W. Decker are the authors of Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations, published by Wiley.

Inhaltsangabe

I - The Neurology of Cognition: Structure and Management of Multiple Memory
Systems in Alzheimer's Disease; Interaction of Neuromodulatory Systems
Regulating Memory Storage; Monoamine and Acetylcholine Influences on Higher
Cognitive Functions in Nonhuman Primates with Relevance to the Treatment of
Alzheimer's Disease; Cortical Acetylcholine and Attention:
Neuropharmacological and Cognitive Principles Directing Treatment
Strategies for Cognitive Disorders; Neuropsychological Features of
Alzheimer's Disease; II - Neuropathological Features of Alzheimer's
Disease; Normal Brain Ageing and Alzheimer's Disease Pathology; Recent
Developments in the Genetics of Alzheimer's Disease; Neurofibrillary
Tangles in Alzheimer's Disease: Clinical and Pathological Implications;
Amyloid Cytoxicity and Alzheimer's Disease: Roles of Membrane Oxidation and
Perturbed Ion Homeostasis; The Role of Apolipoprotein E in Neurobiology and
the Pathogenesis of Alzheimer's Disease; Animal Models Relevant to
Alzheimer's Disease; III - Alzheimer's Drug Discovery and Development:
Alzheimer's Disease: An International Public Health Problem- Clinical
Goals, Strategies and Outcomes; Use of CSF-based Markers in the Diagnosis
of Alzheimer's Disease; Considerations for Clinical Trials in Alzheimer's
Disease; Cholinesterase Inhibition in the Treatment of Alzheimer's Disease:
Further Evaluation of the Clinical Effects of Tucrine; Development of
Muscarinic Agonists for the Symptomatic Treatment of Alzheimer's Disease;
Neuronal Nicotinic Receptors: Potential Treatment for Alzheimer's Disease
with Novel Cholinergic Channel Activators; Neurotrophic Factors: Potential
for Therapeutic Intervention in Alzheimer's Disease; A Fundamental Role for
Estrogens in Cognition and Neuroprotection; Alzheimer's Disease: Prospects
for Treatment in the Next Decade.